Purine metabolism and nucleic acid synthesis machinery

Purine metabolism and nucleic acid synthesis machinery refers to the integrated biochemical pathways responsible for the synthesis, salvage, and degradation of purine nucleotides, as well as their polymerization into DNA and RNA [StatPearls]. This machinery includes de novo synthesis starting from phosphoribosyl pyrophosphate (PRPP) and salvage pathways that recycle free bases like adenine and guanine [NCBI]. These processes are essential for providing the building blocks for genetic material, cellular energy in the form of ATP and GTP, and key signaling molecules [Nature Reviews Cancer]. Because rapidly dividing cells, such as cancer cells and activated lymphocytes, have an increased demand for nucleotides, these pathways are critical therapeutic targets [PubMed]. Drugs targeting this machinery, known as antimetabolites, include methotrexate, which inhibits folate-dependent steps, and thiopurines like 6-mercaptopurine, which act as purine analogs [StatPearls]. While effective in treating malignancies and autoimmune diseases, these agents often cause significant toxicity in high-turnover tissues, leading to side effects such as myelosuppression and gastrointestinal distress [LiverTox]. Selective inhibition of specific enzymes within this machinery, such as inosine monophosphate dehydrogenase (IMPDH), remains a key strategy for developing immunosuppressive and antiviral therapies [PubMed].

Other names

Purine metabolismPurine biosynthetic pathwayNucleotide synthesis machineryPurine salvage pathwayPurine biosynthesis

Inhibition of de novo purine synthesis, inhibition of purine salvage pathways, and incorporation into DNA/RNA as antimetabolites [StatPearls, PubMed].